C. Lindoff et al., PREECLAMPSIA IS ASSOCIATED WITH A REDUCED RESPONSE TO ACTIVATED PROTEIN-C, American journal of obstetrics and gynecology, 176(2), 1997, pp. 457-460
OBJECTIVE: Resistance to activated protein C is an inherited mutation
of the coagulation factor V gene, a major factor predisposing to throm
boembolic events. The purpose of this study was to investigate the occ
urrence of heterozygote and homozygote activated protein C resistance
in women with preeclampsia. STUDY DESIGN: Activated protein C resistan
ce and protein C and antithrombin III levels were determined in women
(n = 50) with a history of preeclampsia and in controls (50 women with
a previous normal pregnancy). The mutation of the factor V gene was a
nalyzed. RESULTS: Activated protein C resistance was found in 22% of w
omen with previous preeclampsia compared with 10% among controls. Two
women in the previous preeclampsia group had a homozygote mutation of
factor V; the others were heterozygous. There was a significant differ
ence in the activated protein C ratio between women with previous pree
clampsia and the control group, 2.6 +/- 0.4 versus 3.1 +/- 0.5 (p = 0.
04). None of the women had protein C or antithrombin III deficiency. C
ONCLUSION: The results indicate that activated protein C resistance ma
y be a contributory factor in the pathogenesis of preeclampsia.